Medical/Pharmaceuticals
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing
WUXI, China, June 21, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it planned to expand the new state-of-the-art ...
2019-06-21 08:39
3567
Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
- Preliminary data shows a high response rate, with 16 of 16 patients achieving complete remission and 14 of 16 patients achieving undetectable minimal residual disease with mild side effect observed - FasT CAR-19 (GC007F) can be manufactured overnight with 100% success - FasT CAR-19 is expecte...
2019-06-21 08:00
3468
Merck's Massachusetts-based Business Sectors Named 'Best Places to Work' by Boston Business Journal
- Life Science, Healthcare and Performance Materials businesses make prestigious Massachusetts top employer list for 2019 DARMSTADT, Germany, June 21, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that itsMassachusetts-based business sectors have been named...
2019-06-21 05:54
3276
Definiens & Targos Innovation: AI-powered multiplex IHC biomarker analytic solutions for precision medicine
Collaboration to bolster end-to-end services from assay development to confident informed clinical decision making MUNICH and KASSEL, Germany, June 20, 2019 /PRNewswire/ -- Definiens, a leading international Artificial Intelligence (AI)–based biomarker analysis and advanced data mining provider ...
2019-06-20 20:00
4678
First-ever successful mind-controlled robotic arm without brain implants
PITTSBURGH, June 20, 2019 /PRNewswire/ -- A team of researchers from Carnegie Mellon University, in collaboration with the University of Minnesota, has made a breakthrough in the field of noninvasive robotic device control. Using a noninvasive brain-computer interface (BCI), researchers have deve...
2019-06-20 02:05
3422
dMed Biopharmaceutical, a next generation CRO, announced the opening of its US Regulatory Affairs office in Washington DC to build a bridge for affordable innovative drugs for US patients
WASHINGTON, June 19, 2019 /PRNewswire/ -- Since the China launch earlier this year of an immuno-oncology drug at one-third the price of Merck's Keytruda, there has been a wave of applications for affordable innovative therapies from China, developed to Western standards of safety and efficacy, ...
2019-06-19 23:59
3171
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the U.S. FDA
SHANGHAI, June 19, 2019 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, today announced that one of its leading drug candidates, CT053 fully human BCMA (B-Cell Maturation Antigen)-CAR-T cell for the trea...
2019-06-19 18:00
4858
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2019
Added 22,194 New Subscribers in 4Q19 4Q19 Revenues Increased by 8.0% YoY to RMB251.7 Million ($37.5 Million) 4Q19 Operating Income Increased to RMB88.9 Million ($13.2 Million) Conference Call to be Held on June 19, 2019 at 8:00 a.m. ET HONG KONG, June 19, 2019 /PRNewswire/ -- Global Cord Blood Corp...
2019-06-19 04:16
11546
Piramal Pharma Solutions recognized by Frost & Sullivan for its End-to-End Integrated Services Across the Entire Drug Development Life Cycle
SANTA CLARA, California, June 18, 2019 /PRNewswire/ -- Based on its recent analysis of the contract development and manufacturing organization market, Frost & Sullivan recognized Piramal Pharma Solutions ('PPS', 'the business') with the 2019 Global Customer Service Leadership Award. Through its 1...
2019-06-18 20:00
1895
Seegene Establishes Brazilian Subsidiary
SEOUL, South Korea, June 18, 2019 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered inSouth Korea, announced today the formation of a new subsidiary, Seegene do Brasil Diagnosticos Ltda., inBelo Horizonte, Brazil. Seegene do Brasil Diagnos...
2019-06-18 19:00
2992
Golden State Killer Case Selected As 2019 DNA Hit Of The Year
The forty-five-year investigation resulted in arrest after law enforcement's use of investigative genetic genealogy KOBE, Japan, June 18, 2019 /PRNewswire/ -- Gordon Thomas Honeywell Governmental Affairs (GTH-GA) has announced that the Golden State Killer case was selected as the 2019 DNA Hit of...
2019-06-18 11:30
2905
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings
SUZHOU, China, June 18, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the clinical results of CT103A, the potential best-in-class therapy of fully-human ...
2019-06-18 08:00
8057
AXA Hong Kong, CUHK and Oxford VR join forces to revolutionise mental health care by launching Asia-first VR therapy solution
HONG KONG, June 17, 2019 /PRNewswire/ -- AXA Hong Kong, The Chinese University of Hong Kong (CUHK) and Oxford VR (OVR) have today jointly launched a first-of-its-kind advanced psychological therapy using virtual reality (VR) technology to support better mental health outcomes inAsia including ...
2019-06-17 19:45
3713
Cedrus' Head of Life Sciences Invited to Moderate a Panel at China Focus@BIO and was a Panelist at the Redefining Early Stage Investments Conference in Philadelphia
HONG KONG, June 17, 2019 /PRNewswire/ -- Ms. Kimberly Nearing, Head of Life
Sciences atCedrus Investments ("Cedrus")
2019-06-17 09:00
3049
Reistone Announces First Patient Dosed in Two Phase II Global Studies of SHR0302 JAK Inhibitor for Ulcerative Colitis and Crohn's Disease
SHANGHAI, June 14, 2019 /PRNewswire/ -- Reistone Biopharma Company Limited (Reistone) announced today dosing of the first patient in their Phase II global clinical trials (RSJ10101 and RSJ10201) of SHR0302 in patients with Ulcerative Colitis and Crohn's disease respectively. The Phase II studies ...
2019-06-14 20:30
2036
First Uzbekistani Company in Hong Kong to bring Chinese Medicine Business along "The Belt and Road"
HONG KONG, June 14, 2019 /PRNewswire/ -- On June 13, "The Belt and Road" International Cocktail Reception of Chinese Medicine Innovation and Cooperation was held inHong Kong by Yilin Bagu Group JV LLC. The event was attended by the delegation of H.E.Bakhtiyor Saidov, Ambassador of Uzbekistan i...
2019-06-14 12:48
8002
China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Lefamulin
- Chinese registrational clinical trial for lefamulin to begin in 2H 2019 BEIJING and SHANGHAI, June 14, 2019 /PRNewswire/ -- Sinovant Sciences today announced that its Clinical Trial Application (CTA) for lefamulin has been accepted by the Center for Drug Evaluation at the China National Medica...
2019-06-14 09:00
5825
New Data Shows The Carillon Mitral Contour System® Is Associated With Improvement In Regurgitant Volume In Patients With Increased Mitral Valve Tenting
Data Presentation & Lunch Symposium at TVT2019 Structural Heart Summit CHICAGO, June 13, 2019 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, presented data at the TVT2019 S...
2019-06-13 21:10
5798
Lumosa to Initiate Phase 2 Human Clinical Trial in the US and Taiwan for Its LT3001, A Novel Drug for the Treatment of Acute Ischemic Stroke
TAIPEI, , June 13, 2019 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; code: 6535.TWO) announced that the company is ready to commence the Phase 2 proof of concept (PoC) study for its LT3001, a novel drug for the treatment of acute ischemic stroke (AIS) that showed good safety, tolerability and ...
2019-06-13 20:00
4397
Avalon GloboCare President and CEO David Jin, M.D., Ph.D. to Chair the "Research and Application of Stem Cell Exosomes" Session at This Year's Second International Aesthetic Industry Conference
Avalon GloboCare to Unveil the Launch of its Exosome Product Commercialization Plan at the Second Aesthetic Industry Conference, the Largest Aesthetics Conference Across Asia Yu Zhou, M.D., Ph.D., Co-CEO of Avalon's subsidiary GenExosome Technologies to provide keynote address FREEHOLD, New Jer...
2019-06-13 20:00
9569
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 318 media titles]
2024-05-07 08:00
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 316 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 309 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 295 media titles]
2024-05-08 16:44
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
14849
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
10421
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9809
